Portfolio comparison
Merck Sharp and Dohme LLC vs Tianjin Genovo Biotechnology Co
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Merck Sharp and Dohme LLC
Patents indexed
1
Year range
2018
Most recent
2018
biotechpharmaceutical
Top Patents1 enriched
US 10028963· 2018
How to Treat Severe Lung Infections Using Ceftolozane and Tazobactam
Activity by Decade
2010s1
Company B
Tianjin Genovo Biotechnology Co
Patents indexed
1
Year range
2025
Most recent
2025
biotechagriculturegene_editing
Top Patents1 enriched
US 12416013· 2025
Boosting Plant Gene Editing and Regeneration with Special Genes
Activity by Decade
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.